‘We learn from everything’
Cancer immunotherapy, 2013 valedictorian, comes of age
By Anette Breindl
Monday, December 23, 2013
In describing how they had decided to name cancer immunotherapy as the 2013 Breakthrough of the Year, the staff of Science magazine also copped to their doubts about whether they had picked the right scientific advance.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.